Hap Trading, LLC Ab Cellera Biologics Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	SELL	$4.29 - $5.97 $858 - $1,194	-200 Reduced 0.31%	65,000 $19.5 Million
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $254,932 - $386,636	65,200 New	65,200 $95.9 Million
Q2 2022 Aug 12, 2022	SELL	$5.72 - $10.65 $637,208 - $1.19 Million	-111,400 Reduced 88.84%	14,000 $22,000
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $89,631 - $122,337	6,900 Added 5.82%	125,400 $7,000
Q3 2021 Nov 10, 2021	BUY	$14.85 - $21.34 $1.58 Million - $2.26 Million	106,100 Added 855.65%	118,500 $159,000
Q2 2021 Aug 11, 2021	BUY	$20.19 - $34.17 $250,356 - $423,708	12,400 New	12,400 $4,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.